Bromovulone III

ID: ALA5285742

Max Phase: Preclinical

Molecular Formula: C21H29BrO4

Molecular Weight: 425.36

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCCCC/C=C\CC1(O)C=C(Br)C(=O)/C1=C\C=C\CCCC(=O)OC

Standard InChI:  InChI=1S/C21H29BrO4/c1-3-4-5-6-9-12-15-21(25)16-18(22)20(24)17(21)13-10-7-8-11-14-19(23)26-2/h7,9-10,12-13,16,25H,3-6,8,11,14-15H2,1-2H3/b10-7+,12-9-,17-13+

Standard InChI Key:  SEUGRXZAXYVQIH-QVOMYVINSA-N

Molfile:  

 
     RDKit          2D

 26 26  0  0  0  0  0  0  0  0999 V2000
    0.5189   -3.4043    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0376   -2.9399    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8345   -3.1535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4178   -2.5701    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2043   -1.7733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7876   -1.1899    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5741   -0.3930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2120    0.0930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8372   -0.3720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6180   -1.1899    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6340   -0.1584    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
   -2.2120    0.9180    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7772   -0.1795    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5637    0.6173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2330    0.8308    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4466    1.6277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2434    1.8412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4570    2.6381    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2538    2.8516    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4673    3.6484    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8371    2.2683    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6340    2.4817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0012   -1.9868    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2933   -3.1199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9268   -3.6484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7012   -3.3641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  6  5  1  0
  6  7  1  0
  7  8  1  0
  9  8  1  0
 10  9  2  0
  6 10  1  0
  9 11  1  0
  8 12  2  0
  7 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  1  0
  6 23  1  0
  1 24  1  0
 24 25  1  0
 25 26  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5285742

    ---

Associated Targets(Human)

Hep 3B2 (2332 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HA22T cell line (61 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 425.36Molecular Weight (Monoisotopic): 424.1249AlogP: 4.93#Rotatable Bonds: 11
Polar Surface Area: 63.60Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 13.42CX Basic pKa: CX LogP: 5.15CX LogD: 5.15
Aromatic Rings: Heavy Atoms: 26QED Weighted: 0.22Np Likeness Score: 2.14

References

1. Ren X, Xie X, Chen B, Liu L, Jiang C, Qian Q..  (2021)  Marine Natural Products: A Potential Source of Anti-hepatocellular Carcinoma Drugs.,  64  (12.0): [PMID:34128674] [10.1021/acs.jmedchem.0c02026]

Source